172 RIGOSERTIB, A NOVEL RAS INHIBITOR, OVERCOMES AZACITIDINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELL LINES. Issue 1 (April 2015) - Cosenza, S.; Oussenko, I.; Divakar, S.; Panda, G.; Reddy, M.; Ohnuma, T.; Reddy, P.